Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 322, Issue 4, Pages H579-H596Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.00666.2021
Keywords
cardiomyocyte; cytokinesis; heart regeneration; proliferation
Funding
- American Heart Association [18CDA34110240, 18CDA34110053, 20TPA35500000]
- National Heart, Lung, and Blood Institute [R01HL155085, R21HL156022, R01HL131788, R01HL133589, R01-HL141159, R01HL138456, R01HL160819, R01HL151386, R01HL151415, R01HL155597, R01HL144938, R01HL135848]
- MCW Cardiovascular Center Grant [FP00012308]
- Advancing a Healthier Wisconsin Endowment [5520561, 5520519]
Ask authors/readers for more resources
The field of mammalian myocardial regeneration has seen significant growth in the past two decades. However, there are limitations and challenges in characterizing cardiomyocyte proliferation. Claims of cardiomyocyte proliferation often lack sufficient evidence or proper controls, and the provided data may only indicate cell-cycle activation or DNA synthesis, without proving the generation of new cardiomyocytes. Rigorous experimental strategies and standards should be used to support claims of proliferation-based remuscularization.
During the past two decades, the field of mammalian myocardial regeneration has grown dramatically, and with this expanded interest comes increasing claims of experimental manipulations that mediate bona fide proliferation of cardiomyocytes. Too often, however, insufficient evidence or improper controls are provided to support claims that cardiomyocytes have definitively proliferated, a process that should be strictly defined as the generation of two de novo functional cardiomyocytes from one original cardiomyocyte. Throughout the literature, one finds inconsistent levels of experimental rigor applied, and frequently the specific data supplied as evidence of cardiomyocyte proliferation simply indicate cell-cycle activation or DNA synthesis, which do not necessarily lead to the generation of new cardiomyocytes. In this review, we highlight potential problems and limitations faced when characterizing cardiomyocyte proliferation in the mammalian heart, and summarize tools and experimental standards, which should be used to support claims of proliferation-based remuscularization. In the end, definitive establishment of de novo cardiomyogenesis can be difficult to prove; therefore, rigorous experimental strategies should be used for such claims.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available